JBT MAREL CORP (JBTM) Stock Fundamental Analysis

USA New York Stock Exchange NYSE:JBTM • US4778391049

166 USD
-0.41 (-0.25%)
At close: Feb 10, 2026
166 USD
0 (0%)
After Hours: 2/10/2026, 8:16:17 PM
Fundamental Rating

3

JBTM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 131 industry peers in the Machinery industry. JBTM has a bad profitability rating. Also its financial health evaluation is rather negative. JBTM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • JBTM had positive earnings in the past year.
  • JBTM had a positive operating cash flow in the past year.
  • JBTM had positive earnings in each of the past 5 years.
  • Each year in the past 5 years JBTM had a positive operating cash flow.
JBTM Yearly Net Income VS EBIT VS OCF VS FCFJBTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

1.2 Ratios

  • The Return On Assets of JBTM (-1.35%) is worse than 73.28% of its industry peers.
  • JBTM has a Return On Equity of -2.50%. This is in the lower half of the industry: JBTM underperforms 71.76% of its industry peers.
  • JBTM has a Return On Invested Capital of 1.95%. This is in the lower half of the industry: JBTM underperforms 69.47% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for JBTM is below the industry average of 10.25%.
Industry RankSector Rank
ROA -1.35%
ROE -2.5%
ROIC 1.95%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
JBTM Yearly ROA, ROE, ROICJBTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • JBTM's Profit Margin has declined in the last couple of years.
  • JBTM has a worse Operating Margin (4.81%) than 62.60% of its industry peers.
  • JBTM's Operating Margin has declined in the last couple of years.
  • JBTM has a Gross Margin of 35.80%. This is in the better half of the industry: JBTM outperforms 66.41% of its industry peers.
  • JBTM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.81%
PM (TTM) N/A
GM 35.8%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
JBTM Yearly Profit, Operating, Gross MarginsJBTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so JBTM is destroying value.
  • Compared to 1 year ago, JBTM has about the same amount of shares outstanding.
  • Compared to 5 years ago, JBTM has more shares outstanding
  • JBTM has a worse debt/assets ratio than last year.
JBTM Yearly Shares OutstandingJBTM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
JBTM Yearly Total Debt VS Total AssetsJBTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • JBTM has an Altman-Z score of 2.06. This is not the best score and indicates that JBTM is in the grey zone with still only limited risk for bankruptcy at the moment.
  • JBTM has a Altman-Z score (2.06) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of JBTM is 6.97, which is on the high side as it means it would take JBTM, 6.97 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of JBTM (6.97) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.43 indicates that JBTM is not too dependend on debt financing.
  • JBTM has a Debt to Equity ratio of 0.43. This is comparable to the rest of the industry: JBTM outperforms 56.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 6.97
Altman-Z 2.06
ROIC/WACC0.21
WACC9.18%
JBTM Yearly LT Debt VS Equity VS FCFJBTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • JBTM has a Current Ratio of 0.93. This is a bad value and indicates that JBTM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of JBTM (0.93) is worse than 88.55% of its industry peers.
  • JBTM has a Quick Ratio of 0.93. This is a bad value and indicates that JBTM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • JBTM has a Quick ratio of 0.53. This is amonst the worse of the industry: JBTM underperforms 89.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.53
JBTM Yearly Current Assets VS Current LiabilitesJBTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

6

3. Growth

3.1 Past

  • JBTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.08%, which is quite impressive.
  • Measured over the past 5 years, JBTM shows a small growth in Earnings Per Share. The EPS has been growing by 0.52% on average per year.
  • JBTM shows a strong growth in Revenue. In the last year, the Revenue has grown by 92.43%.
  • JBTM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.48% yearly.
EPS 1Y (TTM)27.08%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%29.33%
Revenue 1Y (TTM)92.43%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%120.65%

3.2 Future

  • Based on estimates for the next years, JBTM will show a very strong growth in Earnings Per Share. The EPS will grow by 23.91% on average per year.
  • The Revenue is expected to grow by 4.83% on average over the next years.
EPS Next Y25.32%
EPS Next 2Y24.33%
EPS Next 3Y23.91%
EPS Next 5YN/A
Revenue Next Year117.04%
Revenue Next 2Y50.56%
Revenue Next 3Y33.89%
Revenue Next 5Y4.83%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
JBTM Yearly Revenue VS EstimatesJBTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
JBTM Yearly EPS VS EstimatesJBTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 27.21, the valuation of JBTM can be described as expensive.
  • JBTM's Price/Earnings ratio is in line with the industry average.
  • JBTM's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.03.
  • With a Price/Forward Earnings ratio of 21.06, JBTM is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, JBTM is valued a bit cheaper than 66.41% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of JBTM to the average of the S&P500 Index (27.97), we can say JBTM is valued slightly cheaper.
Industry RankSector Rank
PE 27.21
Fwd PE 21.06
JBTM Price Earnings VS Forward Price EarningsJBTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, JBTM is valued a bit more expensive than 69.47% of the companies in the same industry.
  • JBTM's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 31.54
EV/EBITDA 26.52
JBTM Per share dataJBTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

  • JBTM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as JBTM's earnings are expected to grow with 23.91% in the coming years.
PEG (NY)1.07
PEG (5Y)52.56
EPS Next 2Y24.33%
EPS Next 3Y23.91%

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.25%, JBTM is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.15, JBTM has a dividend in line with its industry peers.
  • With a Dividend Yield of 0.25, JBTM pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.25%

5.2 History

  • The dividend of JBTM has a limited annual growth rate of 0.48%.
  • JBTM has been paying a dividend for over 5 years, so it has already some track record.
  • JBTM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.48%
Div Incr Years0
Div Non Decr Years4
JBTM Yearly Dividends per shareJBTM Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

  • The earnings of JBTM are negative and hence is the payout ratio. JBTM will probably not be able to sustain this dividend level.
  • JBTM's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-17.36%
EPS Next 2Y24.33%
EPS Next 3Y23.91%
JBTM Yearly Income VS Free CF VS DividendJBTM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

JBT MAREL CORP

NYSE:JBTM (2/10/2026, 8:16:17 PM)

After market: 166 0 (0%)

166

-0.41 (-0.25%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-03
Earnings (Next)02-23
Inst Owners99.18%
Inst Owner ChangeN/A
Ins Owners0.63%
Ins Owner Change-8.81%
Market Cap8.63B
Revenue(TTM)3.26B
Net Income(TTM)-110.60M
Analysts83.33
Price Target159.94 (-3.65%)
Short Float %4.83%
Short Ratio5.31
Dividend
Industry RankSector Rank
Dividend Yield 0.25%
Yearly Dividend0.41
Dividend Growth(5Y)0.48%
DP-17.36%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.24%
Min EPS beat(2)14.08%
Max EPS beat(2)26.4%
EPS beat(4)3
Avg EPS beat(4)11.49%
Min EPS beat(4)-8.58%
Max EPS beat(4)26.4%
EPS beat(8)5
Avg EPS beat(8)4.11%
EPS beat(12)9
Avg EPS beat(12)6.09%
EPS beat(16)11
Avg EPS beat(16)6.44%
Revenue beat(2)2
Avg Revenue beat(2)3.62%
Min Revenue beat(2)2.12%
Max Revenue beat(2)5.11%
Revenue beat(4)3
Avg Revenue beat(4)0.28%
Min Revenue beat(4)-6.26%
Max Revenue beat(4)5.11%
Revenue beat(8)4
Avg Revenue beat(8)-1.54%
Revenue beat(12)4
Avg Revenue beat(12)-4.62%
Revenue beat(16)5
Avg Revenue beat(16)-3.94%
PT rev (1m)0%
PT rev (3m)8.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.67%
EPS NY rev (1m)0%
EPS NY rev (3m)6.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.75%
Valuation
Industry RankSector Rank
PE 27.21
Fwd PE 21.06
P/S 2.65
P/FCF 31.54
P/OCF 24.43
P/B 1.95
P/tB N/A
EV/EBITDA 26.52
EPS(TTM)6.1
EY3.67%
EPS(NY)7.88
Fwd EY4.75%
FCF(TTM)5.26
FCFY3.17%
OCF(TTM)6.8
OCFY4.09%
SpS62.69
BVpS85.06
TBVpS-22.35
PEG (NY)1.07
PEG (5Y)52.56
Graham Number108.05
Profitability
Industry RankSector Rank
ROA -1.35%
ROE -2.5%
ROCE 2.39%
ROIC 1.95%
ROICexc 1.98%
ROICexgc 10.75%
OM 4.81%
PM (TTM) N/A
GM 35.8%
FCFM 8.4%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
ROICexc(3y)7.1%
ROICexc(5y)8.09%
ROICexgc(3y)24.27%
ROICexgc(5y)25.88%
ROCE(3y)6.33%
ROCE(5y)8.04%
ROICexgc growth 3Y-1.29%
ROICexgc growth 5Y-6.67%
ROICexc growth 3Y-5.85%
ROICexc growth 5Y-12.74%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 6.97
Debt/EBITDA 5.04
Cap/Depr 36%
Cap/Sales 2.45%
Interest Coverage 250
Cash Conversion 93.41%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.53
Altman-Z 2.06
F-Score3
WACC9.18%
ROIC/WACC0.21
Cap/Depr(3y)71.26%
Cap/Depr(5y)66.65%
Cap/Sales(3y)3.61%
Cap/Sales(5y)3.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.08%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%29.33%
EPS Next Y25.32%
EPS Next 2Y24.33%
EPS Next 3Y23.91%
EPS Next 5YN/A
Revenue 1Y (TTM)92.43%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%120.65%
Revenue Next Year117.04%
Revenue Next 2Y50.56%
Revenue Next 3Y33.89%
Revenue Next 5Y4.83%
EBIT growth 1Y-4.04%
EBIT growth 3Y-3.08%
EBIT growth 5Y-9.84%
EBIT Next Year200.73%
EBIT Next 3Y57.42%
EBIT Next 5YN/A
FCF growth 1Y328.68%
FCF growth 3Y4%
FCF growth 5Y22.04%
OCF growth 1Y167.78%
OCF growth 3Y1.15%
OCF growth 5Y16.21%

JBT MAREL CORP / JBTM FAQ

Can you provide the ChartMill fundamental rating for JBT MAREL CORP?

ChartMill assigns a fundamental rating of 3 / 10 to JBTM.


What is the valuation status of JBT MAREL CORP (JBTM) stock?

ChartMill assigns a valuation rating of 3 / 10 to JBT MAREL CORP (JBTM). This can be considered as Overvalued.


How profitable is JBT MAREL CORP (JBTM) stock?

JBT MAREL CORP (JBTM) has a profitability rating of 3 / 10.


What is the financial health of JBT MAREL CORP (JBTM) stock?

The financial health rating of JBT MAREL CORP (JBTM) is 2 / 10.


How sustainable is the dividend of JBT MAREL CORP (JBTM) stock?

The dividend rating of JBT MAREL CORP (JBTM) is 3 / 10 and the dividend payout ratio is -17.36%.